OTC Markets OTCPK - Delayed Quote USD

Welcia Holdings Co., Ltd. (WLCGF)

Compare
16.41
0.00
(0.00%)
At close: March 26 at 4:00:00 PM EDT
Loading Chart for WLCGF
  • Previous Close 0.00
  • Open 16.41
  • Bid 12.36 x 40000
  • Ask 16.10 x --
  • Day's Range 16.41 - 16.41
  • 52 Week Range 16.41 - 16.41
  • Volume 18,166
  • Avg. Volume 0
  • Market Cap (intraday) 3.674B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) 19.54
  • EPS (TTM) 0.84
  • Earnings Date Apr 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Feb 27, 2025
  • 1y Target Est --

Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores offer OTC products, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services, as well as housing services for elderly people. It also engages in the retail of daily necessities, foods, confectionary, alcohol, etc. The company was formerly known as Growell Holdings Co., Ltd. and changed its name to Welcia Holdings Co., Ltd. in September 2012. Welcia Holdings Co., Ltd. was founded in 1935 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.

www.welcia.co.jp

15,286

Full Time Employees

February 29

Fiscal Year Ends

Recent News: WLCGF

View More

Performance Overview: WLCGF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

WLCGF
1,132.08%
Nikkei 225 (^N225)
15.33%

1-Year Return

WLCGF
10,551.80%
Nikkei 225 (^N225)
15.07%

3-Year Return

WLCGF
51,222,175.00%
Nikkei 225 (^N225)
21.79%

5-Year Return

WLCGF
51.36%
Nikkei 225 (^N225)
89.56%

Compare To: WLCGF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WLCGF

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.97B

  • Enterprise Value

    3.04B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.66%

  • Return on Assets (ttm)

    3.69%

  • Return on Equity (ttm)

    8.27%

  • Revenue (ttm)

    1.26T

  • Net Income Avi to Common (ttm)

    20.85B

  • Diluted EPS (ttm)

    0.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    71.63B

  • Total Debt/Equity (mrq)

    32.66%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: WLCGF

View More

Company Insights: WLCGF

Research Reports: WLCGF

View More

People Also Watch